Close Menu
Home » Serametrix Testing Lab Gains CLIA Certification

Serametrix Testing Lab Gains CLIA Certification

Oct 03, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Serametrix, a San Diego-based company specializing in immune monitoring assays, has received CLIA certification for its laboratory in Carlsbad, California, the firm said recently.

The certification enables the company to offer its myeloid-derived suppressor cell assay for cancer patients. The flow cytometry-based assay was developed at the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center and was licensed by Serametrix in 2013.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Cancer

  1. Genetron Health, InnoCare Partner on Cancer Clinical Trial Testing, CDx Development

  2. Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

  3. Radiation-Boosted Liquid Biopsy Shows Promise in Early-Stage Lung Cancer

    Premium

  4. Pan-Cancer Analysis Points to Possible Functional Effects of Passenger Mutations

  5. Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.